Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Vandana Singh

GSK Upgrades 2025 Financial Outlook, CEO Says Positioned Well For 2026

Rueil-malmaison,,France,-,August,13,,2023:,Exterior,View,Of,The

British pharmaceutical giant GSK Plc (NYSE:GSK) on Wednesday reported upbeat third-quarter results and upgraded its full-year 2025 guidance.

GSK's third-quarter sales reached $11.53 billion (8.5 billion British pounds). That’s an 8% increase at constant currency, exceeding analyst estimates of $11.16 billion.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.